A Study in Subjects With Retinitis Pigmentosa

NCT05392179 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aldeyra Therapeutics, Inc.